4//SEC Filing
Marks Gilbert Lynn 4
Accession 0001193125-26-013035
CIK 0001880438other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 5:06 PM ET
Size
4.6 KB
Accession
0001193125-26-013035
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Common Stock
[F1]2026-01-12+11,560→ 75,309 total
Footnotes (1)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
Signature
/s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks|2026-01-14
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001916940
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 5:06 PM ET
- Size
- 4.6 KB